Integrated reverse left and right ventricular remodelling after MitraClip implantation in functional mitral regurgitation: An echocardiographic study

European Heart Journal Cardiovascular Imaging

Volumn 15, Issue 1, 2014, Pages 95-103

  Giannini, Cristina ^a   Petronio, Anna Sonia ^a   De Carlo, Marco ^a   Guarracino, Fabio ^a   Conte, Lorenzo ^a   Fiorelli, Francesca ^a   Pieroni, Andrea ^a   Di Bello, Vitantonio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Percutaneous mitral valve repair

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; DISEASE SEVERITY; EUROSCORE; FEMALE; FOLLOW UP; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEART HEMODYNAMICS; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HEART PERFORMANCE; HEART SIZE; HEART STROKE VOLUME; HEART VENTRICLE FUNCTION; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; IMPLANTABLE CLIP; LUNG ARTERY PRESSURE; MALE; MIDDLE AGED; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; NEW YORK HEART ASSOCIATION CLASS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL PATIENT; SYSTOLIC PULMONARY ARTERY PRESSURE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VERY ELDERLY;

PERCUTANEOUS MITRAL VALVE REPAIR;

AGED; AGED, 80 AND OVER; ECHOCARDIOGRAPHY; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; PROSPECTIVE STUDIES; PUNCTURES; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 84891397151     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jet141     Document Type: Article

References (29)

1. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28: 230-68.
2. Borer JS, Bonow RO. Contemporary approach to aortic and mitral regurgitation. Circulation 2003;108:2432-8.
3. McLaughlin VV, Rich S. Pulmonary hypertension. Curr Probl Cardiol 2004;29: 575-634.
4. Scandura S, Ussia GP, Capranzano P, Caggegi A, Sarkar K, Cammalleri V et al. Left cardiac chambers reverse remodeling after percutaneous mitral valve repair with the MitraClip system. J Am Soc Echocardiogr 2012;25:1099-105.
5. Pleger ST, Schulz-Schönhagen M, Geis N, Mereles D, Chorianopoulos E, Antaredja M et al. One year clinical efficacy and reverse cardiac remodelling in patients with severe mitral regurgitation and reduced ejection fraction after Mitra-Clip(C) implantation. Eur J Heart Fail 2013 (Epub ahead of print).
6. Feldman T,Wasserman HS, Herrmann HC, GrayW, Block PC, Whitlow P et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 2005;46:2134-40.
7. Feldman T, Foster E, Glower DD, Glower DG, Kar S, Rinaldi MJ et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395-406.
8. Feldman T, Cilingiroglu M. Percutaneous leaflet repair and annuloplasty for mitral regurgitation. J Am Coll Cardiol 2011;57:529-37.
9. Horton KD, Meece RW, Hill JC. Assessment of the right ventricle by echocardiography: a primer for cardiac sonographers. J Am Soc Echocardiogr 2009;22:776-92; quiz 861-772.
10. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification: a report from theAmerican Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
11. Whitlow PL, Feldman T, Pedersen WR, Lim DS, Kipperman R, Smalling R et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J AmColl Cardiol 2012;59: 130-9.
12. Franzen O, van der Heyden J, Baldus S, Schlüter M, Schillinger W, Butter C et al. MitraClipw therapy in patients with end-stage systolic heart failure. Eur J Heart Fail 2011;13:569-76.
13. Auricchio A, SchillingerW, Meyer S, Maisano F, Hoffmann R, Ussia GP et al. Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol 2011;58:2183-9.
14. Franzen O, Baldus S, Rudolph V, Meyer S, KnapM, KoschykDet al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 2010;31:1373-81.
15. van der Zwaan HB, Geleijnse ML, McGhie JS, Boersma E, HelbingWA, Meijboom FJ et al. Right ventricular quantification in clinical practice: two-dimensional vs. threedimensional echocardiography compared with cardiac magnetic resonance imaging. Eur J Echocardiogr 2011;12:656-64.
16. Foale R, Nihoyannopoulos P, McKennaW, Kleinebenne A, Nadazdin A, Rowland E et al. Echocardiographic measurement of the normal adult right ventricle. Br Heart J 1986;56:33-44.
17. Chin KM, Kim NH, Rubin LJ. The right ventricle in pulmonary hypertension. Coron Artery Dis 2005;16:13-8.
18. Redington AN, Rigby ML, Shinebourne EA, Oldershaw PJ. Changes in the pressure-volume relation of the right ventricle when its loading conditions are modified. Br Heart J 1990;63:45-9.
19. Henning RJ. Effects of positive end-expiratory pressure on the right ventricle. J Appl Physiol 1986;61:819-26.
20. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part two. Am J Respir Crit Care Med 1994;150:1158-68.
21. Goldhaber SZ, Visani L,DeRosa M. Acute pulmonary embolism: clinical outcomesin the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386-9.
22. Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation 2008;117:1717-31.
23. Wencker D, Borer JS, Hochreiter C, Devereux RB, Roman MJ, Kligfield P et al. Preoperative predictors of late postoperative outcome among patients with nonischemic mitral regurgitation with 'high risk' descriptors and comparison with unoperated patients. Cardiology 2000;93:37-42.
24. Meluzin J, Spinarová L, Hude P, Krejcí J, Kincl V, Panovský R et al. Prognostic importance of various echocardiographic right ventricular functional parameters in patients with symptomatic heart failure. J Am Soc Echocardiogr 2005;18:435-44.
25. Dini FL, Conti U, Fontanive P, Andreini D, Banti S, Braccini L et al. Right ventricular dysfunction is a major predictor of outcome in patients with moderate to severe mitral regurgitation and left ventricular dysfunction. Am Heart J 2007;154:172-9.
26. Pleger ST, Mereles D, Schulz-Schönhagen M, Krumsdorf U, Chorianopoulos E, Rottbauer W et al. Acute safety and 30-day outcome after percutaneous edge-to-edge repair of mitral regurgitation in very high-risk patients. Am J Cardiol 2011;108:1478-82.
27. Neuss M, Schau T, Schoepp M, Seifert M, Holschermann F, Meyhofer J et al. Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure. Eur J Heart Fail 2013;15:786-95.
28. Gaemperli O, Moccetti M, Surder D, Biaggi P, Hurlimann D, Kretschmar O et al. Acute haemodynamic changes after percutaneous mitral valve repair: relation to mid-term outcomes. Heart 2012;98:126-32.
29. Siegel RJ, Biner S, Rafique AM, Rinaldi M, Lim S, Fail P et al. The acute hemodynamic effects of MitraClip therapy. J Am Coll Cardiol 2011;57:1658-65.